Tag
Scientists at Stanford University have created mice with human brain cells to develop a new model for studying human-specific brain disorders like epilepsy, autism, and cerebral palsy, aiming to advance treatment development.
Researchers led by neuroscientist Sergiu Pașca have created mice with human brain cells transplanted into genetically modified cortices, showing improved cognition in maze tests and raising ethical concerns about cross-species brain research.
Brian Armstrong announces that NewLimit has developed a prototype drug that reverses cellular aging in human cells, with a clinical trial scheduled for next year, and has raised $435M in Series C funding led by Founders Fund.